
GFI
48.09 USD
+2.41%
Today
+2.26%
1D
Market is open
Sun
Closed
Mon
3:00 AM ~ 12:00 PM
Tue
12:00 AM ~ 12:00 PM
Wed
12:00 AM ~ 12:00 PM
Thu
12:00 AM ~ 12:00 PM
Fri
12:00 AM ~ 12:00 PM
Sat
Closed
Information
Name
Gold Fields Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0183%
Overnight Fees Sell
0.0016%
Market Cap
36.51B
Avg Daily Volume
3.81M
52 Week High
61.64 USD
52 Week Low
31.11 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01830% | $(0.183) |
| SELLS | 0.00160% | $0.016 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Gold Fields Limited operates as a gold producer with reserves and resources in South Africa, Ghana, Australia, Peru, Canada, and Chile. It also explores for gold, copper and silver deposits. Gold Fields Limited was founded in 1887 and is based in Sandton, South Africa.
Top News
GoldFields
+2.26%
GFI: H1 2026 saw record production, cash flow, and shareholder returns, led by Salares Norte
tradingview.com
38m ago

GoldFields
+2.26%
Gold Fields Returns More Cash to Shareholders as Earnings Jump on Higher Prices
tradingview.com
8h ago

GoldFields
+2.26%
GFI: Record earnings, cash flow from higher gold prices and Salares Norte ramp-up enable $1.25B in shareholder returns
tradingview.com
8h ago

Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.



